The present invention provides a therapeutic method for treating diabetic kidney disease, e.g., diabetic nephropathy that includes the administration of an effective amount of an A2A adenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor. ...http://www.google.co.uk/patents/US20050261236?utm_source=gb-gplus-sharePatent US20050261236 - Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
